Universe Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)3holders
$0.61avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Universe Pharmaceuticals Inc. in their 13F filings. The largest holders were Sabby Management, LLC ($203K), Anson Funds Management LP ($141K) and Morgan Stanley ($40).
- Company
- Universe Pharmaceuticals Inc.
- CUSIP
- G9442G120
- Latest filing quarter
- Q4 2024
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $344K |
| Exits | 0 | $0 |
Ownership 3 holders
| Sabby Management, LLC | 1.66% | New | 333,355 | $203K |
| Anson Funds Management LP | 0.02% | New | 230,407 | $141K |
| Morgan Stanley | 0.00% | New | 65 | $40 |
"% of holder's portfolio" is UNIVERSE PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Universe Pharmaceuticals Inc. the manager owns.